Office of Continuing Medical Education

University of Tennessee Medical Center Heart Lung Vascular Institute and

the University of Tennessee Health Science Center College of Medicine, Knoxville

Present:

29th Annual Heart Lung Vascular Update for the Primary Care Provider

November 7, 2025

Bridgewater Place
205 Bridgewater Road
Knoxville, TN

All registration questions should be referred to the UT Conference Center at (865) 974-0280 or Conferences@utk.edu

Course Overview

This focused update equips primary care providers with the latest strategies for managing cardiovascular and pulmonary conditions commonly encountered in outpatient settings. Participants will review updated guidelines for evaluating chest pain, learn to select appropriate stress testing modalities, and refine their approach to lipid-lowering therapy. The course also highlights key indicators for cardiac amyloidosis in heart failure patients and provides practical guidance on managing antiplatelet and anticoagulant therapies in those with coronary artery disease. Through evidence-based instruction, primary care physicians will leave better equipped to deliver efficient, guideline-based care that improves outcomes for their patients.

Course Objectives

After this program, the participants should be able to:

Apply Updated Guidelines for Chest Pain
Integrate the latest evidence-based guidelines for evaluating and managing patients presenting with chest pain to select the most appropriate care pathways.
Select Appropriate Stress Testing Modalities
Utilize clinical knowledge to determine the most suitable stress testing modality for patients with suspected coronary artery disease (CAD), ensuring accurate diagnosis and efficient use of resources.
Optimize Lipid-Lowering Therapy
Identify patients who would benefit from lipid-lowering interventions based on current guidelines and select the most effective and individualized treatment strategies.
Evaluate for Cardiac Amyloidosis in Heart Failure Patients
Recognize clinical indicators for cardiac amyloidosis in patients with heart failure and determine which patients require further diagnostic evaluation.
Manage Antiplatelet and Anticoagulant Therapy in CAD
Effectively manage dual antiplatelet therapy and anticoagulation in patients with CAD and those who have received coronary stents, adhering to the latest recommendations for minimizing thrombotic and bleeding risks.

Registration Fees

Fees include all program sessions, access to online program materials, continuing education credit, breakfast, breaks, lunch on Friday, and parking at the Bridgewater Place.

Early Bird	October 10
$200	$250

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The University of Tennessee Health Science Center College of Medicine, Knoxville and the University of Tennessee Medical Center Heart Lung Vascular Institute. The University of Tennessee Health Science Center College of Medicine, Knoxville is accredited by the ACCME to provide continuing medical education for physicians

Education Credits

The University of Tennessee Health Science Center College of Medicine, Knoxville designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

-7 MOC points in the American Board of Thoracic Surgery's Maintenance of Certification program; and

-7 MOC points in the American Board of Surgery's (ABS) Maintenance of Certification (MOC) program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABTS or ABS MOC credit.

PAs, NPs, and Nurses: Physician Assistants, Nurse Practitioners, and Nurses may use these credit hours toward certification renewal. This credit is acceptable by the American Academy of Physician Assistants (AAPA), the American Nurses Credentialing Association (ANCC), and the American Academy of Nurse Practitioners (AANP).

Disclosures

There is no minimum threshold for financial disclosures; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies within the past 24 months. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

The UTHSC College of Medicine, Knoxville Office of Continuing Medical Education and the Co-Course Directors have taken appropriate steps to mitigate relationships before the individuals assume their roles. CME Planning Staff have no actual or potential conflicts of interest with the content of the conference.